Perceptive Advisors’s Verona Pharma VRNA Stock Holding History

Perceptive Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-250,000	Closed	-$7.19M	–	120
2024 Q3	$7.19M	Buy	+250,000	New	+$6.15M	0.15%	76
2023 Q3	–	Sell	-500,000	Closed	-$675K	–	106
2023 Q2	$675K	Buy	+500,000	New	+$10.7M	0.02%	87

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Perceptive Advisors's VRNA Position: Q4 2025 in Review

Perceptive Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 524,088 shares — an estimated $55.9M sold.

Perceptive Advisors first reported a position in VRNA in Q2 2017 and held it in 26 quarters. The position peaked at $521M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Perceptive Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Perceptive Advisors sold 524,088 Verona Pharma shares in Q4 2025, an estimated $55.9M.
Perceptive Advisors first reported a position in Verona Pharma in Q2 2017 and held it in 26 quarters.
Perceptive Advisors's Verona Pharma position peaked at $521M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Perceptive Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.